MYLAN 531
Pill imprint MYLAN 531 has been identified as Sulindac 200 mg.
Sulindac is used in the treatment of gout, acute; ankylosing spondylitis; osteoarthritis; pain; familial adenomatous polyposis (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy.
Sulindac 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Sulindac Images
- Imprint:
-
MYLAN 531
- Strength:
- 200 mg
- Color:
- Yellow
- Size:
- 11.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
corn starch
sodium lauryl sulfate
- Drug Class:
- Nonsteroidal anti-inflammatory agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-0531
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0667 | UDL Laboratories Inc |
| 54569-4032 | A S Medication Solutions LLC (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Sulindac resources
Search Again
